Brief: Annexin Announces Outcome Of Rights Issue

Annexin Pharmaceuticals AB (publ)

08/11/2021 15:37

Nov 8 (Reuters) - Annexin Pharmaceuticals AB (publ)  ANNX.ST :
    * ANNEXIN ANNOUNCES OUTCOME OF RIGHTS ISSUE
    * THROUGH RIGHTS ISSUE, ANNEXIN RECEIVES PROCEEDS AMOUNTING TO APPROXIMATELY SEK 73.5M
BEFORE
DEDUCTION OF COSTS RELATED TO RIGHTS ISSUE.
    * REMAINING 16,806,013 UNITS, APPROXIMATELY 28.6 PER CENT OF RIGHTS ISSUE, WERE SUBSCRIBED
FOR BY
GUARANTORS IN RIGHTS ISSUE.
    * THROUGH RIGHTS ISSUE, ANNEXIN RECEIVES PROCEEDS AMOUNTING TO APPROXIMATELY SEK 73.5M
BEFORE
DEDUCTION OF COSTS RELATED TO RIGHTS ISSUE.
    * THROUGH RIGHTS ISSUE, NUMBER OF SHARES IN COMPANY WILL INCREASE BY 58,817,169 SHARES TO
137,240,061, SHARES RESULTING IN AN INCREASE IN SHARE CAPITAL OF SEK 11,763,433.80 TO SEK
27,448,012.2

Source text for Eikon:  ID:nWkr1gWz4T 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))